Probiotics and Paraprobiotics: Effects on Microbiota-Gut-Brain Axis and Their Consequent Potential in Neuropsychiatric Therapy

Samriti Balaji Mudaliar,Sumith Sundara Poojary,Alevoor Srinivas Bharath Prasad,Nirmal Mazumder
DOI: https://doi.org/10.1007/s12602-024-10214-6
2024-02-02
Probiotics and Antimicrobial Proteins
Abstract:Neuropsychiatric disorders are clinical conditions that affect cognitive function and emotional stability, often resulting from damage or disease in the central nervous system (CNS). These disorders are a worldwide concern, impacting approximately 12.5% of the global population. The gut microbiota has been linked to neurological development and function, implicating its involvement in neuropsychiatric conditions. Due to their interaction with gut microbial communities, probiotics offer a natural alternative to traditional treatments such as therapeutic drugs and interventions for alleviating neuropsychiatric symptoms. Introduced by Metchnikoff in the early 1900s, probiotics are live microorganisms that provide various health benefits, including improved digestion, enhanced sleep quality, and reduced mental problems. However, concerns about their safety, particularly in immunocompromised patients, warrant further investigation; this has led to the concept of "paraprobiotics", inactivated forms of beneficial microorganisms that offer a safer alternative. This review begins by exploring different methods of inactivation, each targeting specific cellular components like DNA or proteins. The choice of inactivation method is crucial, as the health benefits may vary depending on the conditions employed for inactivation. The subsequent sections focus on the potential mechanisms of action and specific applications of probiotics and paraprobiotics in neuropsychiatric therapy. Probiotics and paraprobiotics interact with gut microbes, modulating the gut microbial composition and alleviating gut dysbiosis. The resulting neuropsychiatric benefits primarily stem from the gut-brain axis, a bidirectional communication channel involving various pathways discussed in the review. While further research is needed, probiotics and paraprobiotics are promising therapeutic agents for the management of neuropsychiatric disorders.
biotechnology & applied microbiology,microbiology
What problem does this paper attempt to address?
The paper primarily explores the potential roles of probiotics and paraprobiotics in the treatment of neuropsychiatric disorders and their impact on the gut-brain axis (GBA). ### Core Issues of the Paper - **Background**: Neuropsychiatric disorders (such as anxiety disorders, bipolar disorder, major depressive disorder, etc.) affect approximately 12.5% of the global population. These diseases are related to central nervous system (CNS) damage or diseases. Research has found a connection between the gut microbiota and neurodevelopment and function, suggesting that gut microbes may be involved in the pathogenesis of neuropsychiatric disorders. - **Role of Probiotics**: Probiotics, as live microorganisms, can improve digestion, sleep quality, and alleviate psychological issues by regulating the gut microbiota. However, safety concerns for immunocompromised patients have prompted researchers to explore the concept of "paraprobiotics"—the non-viable forms of beneficial microorganisms. - **Advantages of Paraprobiotics**: Paraprobiotics do not contain live microorganisms, thus avoiding the safety issues associated with traditional probiotics. They provide health benefits through various pathways, including immunomodulation, anti-inflammatory, antioxidant, and antihypertensive effects. ### Summary of Main Content - **Microbiota-Gut-Brain Axis (GBA)**: The article elaborates on the concept of GBA and how probiotics and paraprobiotics can influence neuropsychiatric symptoms by regulating the gut microbiota. - **Mechanisms of Probiotics and Paraprobiotics**: It explores how probiotics and paraprobiotics affect neuropsychiatric symptoms through the bidirectional communication channels of the GBA, including the vagus nerve, immune activity, inflammatory reflex and neuroinflammation, microbial metabolites, and neuroactive compounds. - **Applications of Probiotics and Paraprobiotics**: It discusses the specific applications of probiotics and paraprobiotics in alleviating neuropsychiatric symptoms, including results from preclinical studies and clinical trials. ### Conclusion - The paper emphasizes the potential of probiotics and paraprobiotics in the management of neuropsychiatric disorders, particularly in alleviating symptoms by regulating the gut microbiota. Although further research is needed to validate their efficacy, probiotics and paraprobiotics offer new possibilities for treating these disorders. - Paraprobiotics have higher safety compared to traditional probiotics, especially for immunocompromised patients, making them an attractive therapeutic option.